The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 4th 2024
A review of 5 highly anticipated FDA decisions expected by year-end, including acoramidis for ATTR-CM, olezarsen for FCS, sotagliflozin for T1D and CKD, and more.
September 18th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Seas of Change for Inpatient Glucose Management
September 4th 2009Making the transition from outpatient to inpatient has been thankfully only a slightly “bumpy” road, but it is amazing looking back on how our approach to inpatient diabetes care and hyperglycemia on the whole has changed over the past 10 years.
Antihypertensive Combination Drugs: Effectiveness, Adherence, and Pleiotropic Effects
The decreasing age of onset of hypertension in the general population paired with increasing life expectancy has resulted in an increased incidence of this disorder, which will likely culminate in higher rates of morbidity and mortality in the future.
FDA Warns on Potentially Fatal Glucose Monitor Readings
August 18th 2009Due to results that could mask significant hypoglycemia or prompt excessive insulin use, diabetics should never use GDH-PQQ glucose meters or test strips while using drug products or therapies that contain certain sugars other than glucose.
Bonus or Bogus? Are federal funds for health IT a true stimulus, or merely a stopgap?
What do physicians really think about the HITECH act, health IT stimulus incentives, and the government’s new role in their lives? Using the power of social media, we did a little research and asked MDNG readers to share their opinions, concerns, and advice.